Alpha Cognition (ACOG): 10% owner bought ~$42K

~$42K

Approx. value · 7,358 sh @ $5.75

2.43M

Holds after · shares reported

Traded

Mar 13, 2026

Filed

Mar 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 9, 2026, the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Alpha Cognition Inc. (the “Company”) granted equity awards under the Company’s 2025 Stock and Incentive Plan to its named executive officers.”
2. Feb 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 18, 2026, Len Mertz, a member of the board of directors (the “ Board ”) of Alpha Cognition Inc. (the “ Company ”), notified the Board that he does not intend to stand for re-election at the Company’s 2026 annual meeting (the “ 2026 Annual Meeting ”).”
3. Feb 20, 2026Insider · 1 personInsiders: 2 purchases (~$75K)
4. Feb 23, 2026Insider · 1 personInsiders: 2 purchases (~$589K)
5. Feb 24, 2026Insider · 1 personInsiders: 2 purchases (~$340K)
6. Feb 26, 2026Insider10% owner purchased ~$3.5K of ACOG shares in the open market
7. Feb 27, 2026Insider10% owner purchased ~$22K of ACOG shares in the open market
8. Mar 2, 2026Insider10% owner purchased ~$116K of ACOG shares in the open market
9. Mar 3, 2026Insider · 1 personInsiders: 2 purchases (~$296K)
10. Mar 4, 2026Insider10% owner purchased ~$115K of ACOG shares in the open market
11. Mar 5, 2026Insider · 1 personInsiders: 2 purchases (~$273K)
12. Mar 6, 2026Insider10% owner purchased ~$11K of ACOG shares in the open market
13. Mar 9, 2026Insider10% owner purchased ~$13K of ACOG shares in the open market
14. Mar 12, 2026Insider · 13 days before results10% owner purchased ~$33K of ACOG shares in the open market
15. Mar 13, 2026 · this disclosureInsider · 12 days before results10% owner purchased ~$42K of ACOG shares in the open market

What came next

1. Mar 16, 2026Insider · 9 days before results10% owner purchased ~$7.7K of ACOG shares in the open market
2. Mar 18, 2026Insider · 7 days before results10% owner purchased ~$14K of ACOG shares in the open market
3. Mar 19, 2026Insider · 6 days before results10% owner purchased ~$12K of ACOG shares in the open market
4. Mar 24, 2026Insider · 1 day before results10% owner purchased ~$23K of ACOG shares in the open market
5. Mar 25, 2026Company filing · Form 8-K · ResultsReported its results
6. Mar 25, 2026Insider10% owner purchased ~$47K of ACOG shares in the open market
7. Mar 26, 2026Insider10% owner purchased ~$39K of ACOG shares in the open market
8. Mar 27, 2026Insider10% owner purchased ~$51K of ACOG shares in the open market
9. Mar 30, 2026Insider10% owner purchased ~$9.2K of ACOG shares in the open market
10. Apr 10, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
11. Apr 15, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 15, 2026, the Board appointed Bethany Sensenig as a director of the Company. Ms. Sensenig was most recently Chief Financial Officer and Head of Operations at Radius Health, Inc (May 2024 to April 2026), a commercial stage biopharmaceutical company, where she played a critical leadership role in the growth, financial performance, and sale of the company.”
12. Apr 15, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 28, 2026, the Board appointed Ms. Sensenig as a member of the Audit Committee of the Board and as a member of the Governance and Nomination Committee of the Board.”
13. May 15, 2026Insider10% owner purchased ~$97K of ACOG shares in the open market
14. May 18, 2026Insider10% owner purchased ~$99K of ACOG shares in the open market
15. May 19, 2026Insider · Their first buy on recordOfficer purchased ~$20K of ACOG shares in the open market
16. May 20, 2026Insider10% owner purchased ~$50K of ACOG shares in the open market
17. May 21, 2026Insider10% owner purchased ~$91K of ACOG shares in the open market
18. May 27, 2026Insider10% owner purchased ~$6.7K of ACOG shares in the open market
19. May 28, 2026Insider10% owner purchased ~$12K of ACOG shares in the open market
20. May 29, 2026Insider10% owner purchased ~$416K of ACOG shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alpha Cognition

For Alpha Cognition, OQRO holds 12 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACOG page.

Other recent filings by Opaleye Management Inc., 10% owner

• SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
• SEC Form 4 at Grace Therapeutics (GRCE)Oct 26, 2026
• SEC Form 4 at Alpha Cognition (ACOG)Oct 26, 2026

The full history of Opaleye Management Inc., 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Alpha Cognition

• SEC Form 4Oct 26, 2026
• SEC Form 4Oct 26, 2026
• SEC Form 4Oct 19, 2026
• SEC Form 4Oct 19, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 28, 2026

Everything OQRO holds on this company is on its ACOG page.